Skip to main content
Clinical Trials/IRCT20140818018842N15
IRCT20140818018842N15
Completed
Phase 3

The randomized, double -blinded clinical trial comparing gonadotropin – releasing hormone agonist injection effect before frozen embryo transfer versus placebo on improving the outcome of pregnancy in infertile patients with hyper androgenic polycystic ovary syndrome in the IVF/ICSI cycle

Deputy of Research and Technology, Tehran University of Medical Sciences.0 sites74 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Deputy of Research and Technology, Tehran University of Medical Sciences.
Enrollment
74
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Deputy of Research and Technology, Tehran University of Medical Sciences.

Eligibility Criteria

Inclusion Criteria

  • Oligoovulation or anovulation.
  • Clinical and/or biochemical signs of hyperandrogenism.
  • Polycystic ovaries.

Exclusion Criteria

  • Patients with hyperanderogenism caused by hormonal drugs or other medications.
  • Patients who have known sever organ dysfunction or mental illness.
  • Pregnant women or being in Post\- miscarriage period
  • breastfeeding
  • being in the 6 week postpartum period.
  • Patients had congenital adrenal hyperplasia or were suspected of having Cushing s syndrome or an androgen – screening neoplasm.

Outcomes

Primary Outcomes

Not specified

Similar Trials